Results 1 to 10 of about 39,096 (340)

Management of chemotherapy induced emesis [PDF]

open access: yesArchive of Oncology, 2004
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj   +3 more sources

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

open access: yesBMC Cancer, 2021
Background Among patients with colorectal cancer (CRC) treated with oxaliplatin (L-OHP)-based chemotherapy, delayed chemotherapy-induced nausea and vomiting (CINV) have not been well controlled.
Mototsugu Shimokawa   +8 more
doaj   +1 more source

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

open access: yesFrontiers in Oncology, 2021
IntroductionThe aim of this study is to rigorously review the efficacy and safety of olanzapine in chemotherapy-induced nausea and vomiting (CINV) settings including (1) at 5- and 10-mg doses, and (2) the setting of highly emetogenic chemotherapy (HEC ...
Dong-Yang Wang   +3 more
doaj   +1 more source

Prophylaxis of postoperative nausea and vomiting with combination of ondansetron and dexametasone in urology: Prophylaxis of postoperative nausea and vomiting [PDF]

open access: yesSerbian Journal of Anesthesia and Intensive Therapy, 2016
Introduction: Postoperative nausea and vomiting is an unpleasant, distressing and exhausting experience for patients. There are inconsistent findings concerning approach to the management of PONV and disagreement as to whether prophylaxis of PONV should ...
Gvozdić Branka   +2 more
doaj   +1 more source

Pediatric related risk factors in acute and delayed chemotherapyinduced nausea and vomiting: multivariate analysis

open access: yesBrazilian Journal of Oncology, 2022
Objectives: This study aimed to characterize the clinical profile and the factors that predispose chemotherapy-induced nausea and vomiting (CINV) in the acute and delayed phases. Methods: A retrospective cohort study
Ariádne Sousa Albuquerque   +5 more
doaj   +1 more source

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

open access: yesFrontiers in Oncology, 2020
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance ...
Ashok K. Vaid   +10 more
doaj   +1 more source

Rotatory nystagmus after granisetron administration

open access: yesSaudi Journal of Emergency Medicine, 2021
Background: Granisetron is a popular antiemetic medication used in the emergency department to control nausea and vomiting with an excellent side effect profile among adults and pediatric, in both healthy and oncology patients.
Abdulelah Shafiq Abualfraj   +3 more
doaj   +1 more source

What are the effects of drugs for nausea and vomiting prevention following general anesthesia? Summary and comments regarding a Cochrane Collaboration network meta-analysis

open access: yesColombian Journal of Anesthesiology, 2023
The aim of this special article is to summarize and discuss, from an anesthesia perspective, the network meta-analysis on drugs used for the prevention of postoperative nausea and vomiting after general anesthesia, in agreement with the Cochrane Colombia
Mario Zamudio Burbano   +2 more
doaj   +1 more source

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2023
Background/Aims We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC).
Der Sheng Sun   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy